Avalyn Pharma Reports Third Quarter 2026 Financial Results and Business Highlights
Avalyn Pharma announced its financial results for the third quarter ended September 30, 2026, and provided updates on its clinical pipeline, including the initiation of a Phase 1 study for AP03.